You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 24, 2025

Drugs Containing Excipient (Inactive Ingredient) POLYETHYLENE GLYCOL 300


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing POLYETHYLENE GLYCOL 300 excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing POLYETHYLENE GLYCOL 300 excipient

Market Dynamics and Financial Trajectory for Polyethylene Glycol 300

Introduction to Polyethylene Glycol 300

Polyethylene Glycol 300 (PEG 300) is a versatile and widely used pharmaceutical excipient, known for its multiple applications across various industries, including pharmaceuticals, cosmetics, and personal care. Here, we delve into the market dynamics and financial trajectory of PEG 300, highlighting key trends, drivers, and challenges.

Market Size and Growth Projections

The global Polyethylene Glycol (PEG) market, which includes PEG 300, is anticipated to experience significant growth over the next decade. According to market forecasts, the PEG market is expected to grow from USD 4,284.0 million in 2024 to USD 7,999.4 million by 2034, at a Compound Annual Growth Rate (CAGR) of 6.4%[2].

Segment Analysis

By Form

PEG 300, which falls under the liquid segment, is one of the most widely used forms of PEG. The liquid segment dominates the market with a 54.9% share in 2024, driven by its versatility and multi-application bases, particularly in pharmaceutical and cosmetic industries[2].

By Application

The pharmaceutical sector is a major driver for PEG 300, with this segment expected to generate around 33.1% of the market share in 2024. PEG 300 is used as a binder, filler, and solvent in various pharmaceutical formulations, including tablets, topical preparations, and moisturizers[2].

Drivers of Market Growth

Increasing Demand in Pharmaceuticals

The growing demand for medicines and advancements in pharmaceutical research and development are key drivers for the PEG 300 market. Technological advancements in drug delivery systems and the increasing focus on patient-specific medicines further bolster the demand for PEG 300[4].

Cosmetics and Personal Care

The cosmetics and personal care industries also contribute significantly to the demand for PEG 300. Its non-toxic and water-soluble properties make it an ideal ingredient for moisturizers, topical preparations, and other consumer products[2].

Sustainability and Eco-Friendliness

As consumers and manufacturers increasingly focus on sustainability, PEG 300's biodegradable nature is expected to drive its demand, especially in cosmetics and personal care formulations[2].

Challenges and Restraints

Raw Material Volatility

The price of ethylene oxide, the primary raw material for manufacturing PEGs, can be volatile due to global supply and demand scenarios, as well as macroeconomic and political factors. This volatility can impact the production costs and profitability of PEG 300[2].

Regulatory and Quality Compliance

Stringent regulatory requirements, especially in the pharmaceutical sector, necessitate significant investments in quality management, testing, and compliance. Smaller manufacturers may find it challenging to absorb these costs, which can be a barrier to entry and growth[2].

Energy and Environmental Costs

The high cost of managing energy, raw materials, and environmental compliance adds to the financial challenges faced by manufacturers of PEG 300[2].

Regional Analysis

Europe

Europe is a lucrative region for PEG 300, driven by its well-established pharmaceutical industry, stringent regulatory compliance, and robust healthcare infrastructure. The region's emphasis on research and development further contributes to its attractiveness[4].

Asia Pacific

The Asia Pacific region is poised for rapid growth, driven by the burgeoning pharmaceutical sector, increasing healthcare investments, and a rapidly evolving market landscape. This region offers significant opportunities for the expansion of PEG 300 markets[4].

Financial Trajectory

Revenue Projections

The global PEG market, including PEG 300, is projected to reach USD 7,999.4 million by 2034. Specifically, the pharmaceutical-grade PEG market, which includes PEG 300, is expected to grow from USD 1,166.62 million in 2023 to USD 1,731.73 million by 2030, at a CAGR of 5.87%[4].

Market Share

In terms of market share, the liquid segment, which includes PEG 300, holds a significant portion, with 54.9% of the market share in 2024. The pharmaceutical application segment is expected to dominate, generating around 33.1% of the market share in the same year[2].

Impact of COVID-19

The COVID-19 pandemic had a mixed impact on the PEG 300 market. While some segments, such as personal care and pharmaceuticals, benefited from increased awareness of hygiene and health, others faced supply chain and production disruptions. However, the post-pandemic recovery and strong healthcare investments have reinvigorated demand for PEG 300 across most end-use applications[2].

Key Takeaways

  • Growth Projections: The PEG market, including PEG 300, is expected to grow significantly, reaching USD 7,999.4 million by 2034.
  • Segment Dominance: The liquid segment, which includes PEG 300, dominates the market with a 54.9% share.
  • Pharmaceutical Demand: The pharmaceutical sector is a major driver, with PEG 300 used extensively in drug formulations.
  • Sustainability: The biodegradable nature of PEG 300 is expected to drive demand in sustainable and eco-friendly formulations.
  • Challenges: Volatility in raw material prices, regulatory compliance, and energy costs are significant challenges.

FAQs

Q: What is the expected growth rate of the Polyethylene Glycol market from 2024 to 2034?

A: The Polyethylene Glycol market is expected to grow at a CAGR of 6.4% from 2024 to 2034[2].

Q: Which segment dominates the Polyethylene Glycol market?

A: The liquid segment, which includes PEG 300, dominates the market with a 54.9% share in 2024[2].

Q: What are the primary applications of PEG 300?

A: PEG 300 is primarily used in the pharmaceutical, cosmetics, and personal care industries as a binder, filler, and solvent[2].

Q: How has the COVID-19 pandemic impacted the PEG 300 market?

A: The pandemic had a mixed impact, with some segments benefiting from increased hygiene awareness, while others faced supply chain disruptions. Post-pandemic recovery has reinvigorated demand[2].

Q: What are the key challenges facing PEG 300 manufacturers?

A: Key challenges include volatility in raw material prices, stringent regulatory compliance, and high energy and environmental costs[2].

Sources:

  1. Data Bridge Market Research - Global Polyethylene Glycol Market Size, Outlook, & Industry Trends By 2030
  2. Future Market Insights - Polyethylene Glycol Market Insights by Form & Application to 2034
  3. Research and Markets - Pharmaceutical Excipients Global Market Report 2024
  4. Verified Market Research - Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size ...
  5. Data Bridge Market Research - North America Polyethylene Glycol Market Size, Share & Outlook By ...

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.